Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in endocrinology, May 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 14 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,417 followers.

RT @PhRheumaJr: SGLT2i use was associated with a 34% reduced risk of #gout among patients with T2DM https://t.co/wmoIkvlRRF

30 Jul 2023

Reply Repost Favourite

SGLT2i use was associated with a 34% reduced risk of #gout among patients with T2DM https://t.co/wmoIkvlRRF

29 Jul 2023

Reply Repost Favourite

New Research: Sodium-glucose cotransporter-2 inhibitors use and the risk of gout: a systematic review and meta-analysis: Objective To assess the relationship between use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) and the… #Endocrinology #Endo h

23 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.